Critical Insights From Travere Therapeutics Analyst Ratings: What You Need To Know
Critical Insights From Travere Therapeutics Analyst Ratings: What You Need To Know
来自Travere Therapeutics分析师评级的关键见解：你需要知道的
4 analysts have shared their evaluations of Travere Therapeutics (NASDAQ:TVTX) during the recent three months, expressing a mix of bullish and bearish perspectives.
4位分析师分享了他们最近三个月对Travere Therapeutics（纳斯达克股票代码：TVTX）的评估，表达了看涨和看跌的观点。
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
下表简要概述了他们最近的评级，重点介绍了过去30天中情绪的变化，并将其与前几个月进行了比较。
Analysts have set 12-month price targets for Travere Therapeutics, revealing an average target of $13.0, a high estimate of $17.00, and a low estimate of $9.00. This current average reflects an increase of 4.0% from the previous average price target of $12.50.
分析师已经为Travere Therapeutics设定了12个月的目标股价，显示平均目标股价为13.0美元，最高估计为17.00美元，低估值为9.00美元。目前的平均价格比之前的平均目标价12.50美元增长了4.0％。
Understanding Analyst Ratings: A Comprehensive Breakdown
了解分析师评级：全面细分
The analysis of recent analyst actions sheds light...
对分析师最近行为...
登录免费看全文
登录/注册